Skip to main content
Heidi Cuthbert CEO Grafa
Heidi Cuthbert

Heidi Cuthbert

GrafaCEO & Founder

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.

Articles by Heidi Cuthbert

Grafa
Health

Ultragenyx setrusumab misses primary endpoints in Phase 3 osteogenesis imperfecta trials

Ultragenyx Pharmaceutical (NASDAQ:RARE) Phase 3 trials of setrusumab (UX143) in osteogenesis imperfecta failed to meet their primary endpoints, prompting the company to plan significant expense reductions while it evaluates next steps for the program.

Read more: Ultragenyx setrusumab misses primary endpoints in Phase 3 osteogenesis imperfecta trials